Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Zini

Showing results (11-20 of 110) with videos related to

Pageof 11
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1993
Nucleotides modulate the low affinity binding sites for [3H]glibenclamide in the rat brainS Zini, R Zini, Y Ben-Ari
Biochemical Pharmacology|March 1, 1982
Multiple human serum binding of two thienopyridinic derivatives, ticlopidine and PCR 2362, and their distribution between HSA, alpha1-acid glycoprotein and lipoproteinsS Glasson, R Zini, J P Tillement
The Journal of Pharmacy and Pharmacology|August 1, 1983
Dependence of drug-protein binding parameters on human serum and albumin concentrationF Brunner, R Zini, J P Tillement
Progress in Clinical and Biological Research|January 1, 1989
1-anilino-naphthalene 8-sulfonic acid (ANS) as a probe for the binding of antidepressant drugs to human alpha 1-acid glycoprotein (AAG)R Zini, C Copigneaux, J P Tillement
Infection|January 1, 1982
[The binding of erythromycin to proteins in the serum of humans during various infections (author's transl)]J Barré, R Zini, J P Tillement
Journal of Pharmaceutical Sciences|January 1, 1990
Use of 1-anilino-8-naphthalene sulfonate as a fluorescent probe in the investigation of drug interactions with human alpha-1-acid glycoprotein and serum albuminD Essassi, R Zini, J P Tillement
The Journal of Pharmacy and Pharmacology|December 1, 1991
The blood binding of cefotiam and cyclohexanol, metabolites of the prodrug cefotiam hexetil, in-vitroV Querol-Ferrer, R Zini, J P Tillement
Clinical Pharmacokinetics|August 1, 1990
Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part I)R Zini, P Riant, J Barré, et al.
Clinical Pharmacokinetics|September 1, 1990
Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part II)R Zini, P Riant, J Barré, et al.
La Clinica Terapeutica|June 30, 1982
[Clinical pharmacology of the hemocoagulase isolated from Bothrops jararaca venom]F Pupita, V Di Placido, R Zini, et al.
Pageof 11

Showing results (11-20 of 110) with videos related to

Sort By:
Pageof 11
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1993
Nucleotides modulate the low affinity binding sites for [3H]glibenclamide in the rat brainS Zini, R Zini, Y Ben-Ari
Biochemical Pharmacology|March 1, 1982
Multiple human serum binding of two thienopyridinic derivatives, ticlopidine and PCR 2362, and their distribution between HSA, alpha1-acid glycoprotein and lipoproteinsS Glasson, R Zini, J P Tillement
The Journal of Pharmacy and Pharmacology|August 1, 1983
Dependence of drug-protein binding parameters on human serum and albumin concentrationF Brunner, R Zini, J P Tillement
Progress in Clinical and Biological Research|January 1, 1989
1-anilino-naphthalene 8-sulfonic acid (ANS) as a probe for the binding of antidepressant drugs to human alpha 1-acid glycoprotein (AAG)R Zini, C Copigneaux, J P Tillement
Infection|January 1, 1982
[The binding of erythromycin to proteins in the serum of humans during various infections (author's transl)]J Barré, R Zini, J P Tillement
Journal of Pharmaceutical Sciences|January 1, 1990
Use of 1-anilino-8-naphthalene sulfonate as a fluorescent probe in the investigation of drug interactions with human alpha-1-acid glycoprotein and serum albuminD Essassi, R Zini, J P Tillement
The Journal of Pharmacy and Pharmacology|December 1, 1991
The blood binding of cefotiam and cyclohexanol, metabolites of the prodrug cefotiam hexetil, in-vitroV Querol-Ferrer, R Zini, J P Tillement
Clinical Pharmacokinetics|August 1, 1990
Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part I)R Zini, P Riant, J Barré, et al.
Clinical Pharmacokinetics|September 1, 1990
Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part II)R Zini, P Riant, J Barré, et al.
La Clinica Terapeutica|June 30, 1982
[Clinical pharmacology of the hemocoagulase isolated from Bothrops jararaca venom]F Pupita, V Di Placido, R Zini, et al.
Pageof 11